(RTTNews) - AbbVie (ABBV) announced the FDA has approved JUVMO tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease. The approval is supported by the Phase …
(RTTNews) - Burford Capital Limited (BUR, BUR.L) issued a statement regarding the verdict, in a case captioned Taction Technology, Inc. v. Apple Inc., which represents one of the largest patent verdicts in U.S. history.…
The S&P 500 Index ($SPX) (SPY) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.42%. December E-mini S&P futures (ESZ…
(RTTNews) - Kodiak Sciences Inc. (KOD), a pre-commercial, retina-focused biotechnology company, is expected to report topline results from DAYBREAK, a Phase 3 study evaluating both Zenkuda (tarcocimab tedromer) and KSI-…
(RTTNews) - European stocks are seen opening on a cautious note on Monday due to continued uncertainty over the end to the U.S.-Iran war in the Middle East after U.S. President Donald Trump rejected Iran's latest propos…
(RTTNews) - Agfa-Gevaert (AGFB.BR), an imaging technology company, on Monday announced that it has entered into a definitive agreement with Electronics for Imaging to combine Agfa's Digital Printing Solutions business w…
(RTTNews) - Innovent Biologics, Inc. (1801.HK), a biopharmaceutical company focused on developing therapies across oncology and other major diseases, announced the expansion of the global Phase 3 MarsLight-11 study of I…
(RTTNews) - The Australian stock market is modestly higher on Monday, reversing some of the losses in the previous two sessions, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 …
(RTTNews) - The Hong Kong stock market has finished lower in back-to-back sessions, slumping almost 280 points or 1.1 percent in that span. The Hang Seng Index now sits just beneath the 25,330-point plateau although it …
(RTTNews) - NIO Inc. (NIO,NIO.SI,9866.HK) announced that it has entered into definitive agreements with subsidiaries of Zhejiang Geely Holding Group to form a strategic partnership in battery swapping and charging, adva…
Bristol Myers Squibb's Growth Portfolio sales rose 15% in the second quarter, and management raised its 2026 revenue guidance to $49 billion to $50 billion.
Nvidia (NASDAQ:NVDA) and SpaceX (NASDAQ:SPCX) are two of the most valuable companies in the world, and they're also two of the most talked-about stocks.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.